Emmanuel J Favaloro/LinkedIn
Nov 12, 2025, 10:55
Thrombophilia Testing․ What’s New and What Still Matters?
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn.
” Latest publication from the Sydney Centres for Thrombosis and Haemostasis based at Westmead Hospital. Editorial on thrombophilia testing; free to download from here
but only for the first 50 visits. Thereafter, standard access applies; send me an email if you want a copy but can’t access through your institution.”
Stay updated with Hemostasis Today.
-
May 30, 2026, 15:17Jean Connors: Celebrating World Thrombosis Day with Global Colleagues in Japan
-
May 30, 2026, 14:56Ifeanyichukwu Ifechidere: The Science Behind Every Coagulation Result
-
May 30, 2026, 14:52Abdul Mannan: Managing Bleeding in Acquired Haemophilia A – Choosing the Right Haemostatic Strategy
-
May 30, 2026, 14:36Mona Ranade: Joining Experts to Advance Acute Pulmonary Embolism Care at the PE Virtual Connection Forum
-
May 30, 2026, 14:25Rena D. Sukhdeo Singh: Celebrating the Launch of Stroke Smart West Virginia
-
May 30, 2026, 14:11Monica Verduzco-Gutierrez: A New Spasticity Education and Patient Journey Resource for Stroke Awareness Month Is Now Live
-
May 30, 2026, 13:59Chinua Onyebuchi: Proud to Contribute to The Wider Mission of The British Heart Foundation and The Stroke Association
-
May 30, 2026, 13:52Gerrit M. Grosse: How Integrative Biomarker Approaches May Improve Our Understanding of Brain-Immune Crosstalk After Stroke
-
May 30, 2026, 13:15Highlight Groundbreaking and Emerging Science From the Posters by Leading an ASH Poster Walk at ASH26